Skip to main content
. 2015 Jun 18;21(1):544–552. doi: 10.2119/molmed.2015.00063

Figure 1.

Figure 1

Intrathecal injection delivery of AAV vectors. (A) A diagram showing the AAV-shRNA vector used to target Nav1.3 in vivo (adapted from Samad et al., 2013 [5]). (B) A small laminectomy was performed between vertebral columns L5 and L6. AAV-vectors were then injected into intrathecal space and resulted in vector transduction of DRGs along the lumbar enlargement.